These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 36382580)

  • 21. METTL3 promotes colorectal cancer metastasis by promoting the maturation of pri-microRNA-196b.
    Huang L; Liang D; Zhang Y; Chen X; Chen J; Wen C; Liu H; Yang X; Yang X; Lin S
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):5095-5108. PubMed ID: 36348020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.
    Xie W; Ma LL; Xu YQ; Wang BH; Li SM
    Biochem Biophys Res Commun; 2019 Oct; 518(1):120-126. PubMed ID: 31405565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. METTL3 promotes colorectal cancer metastasis by stabilizing PLAU mRNA in an m6A-dependent manner.
    Yu T; Liu J; Wang Y; Chen W; Liu Z; Zhu L; Zhu W
    Biochem Biophys Res Commun; 2022 Jul; 614():9-16. PubMed ID: 35567945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. METTL3-mediated m6A modification of STEAP2 mRNA inhibits papillary thyroid cancer progress by blocking the Hedgehog signaling pathway and epithelial-to-mesenchymal transition.
    Zhu Y; Peng X; Zhou Q; Tan L; Zhang C; Lin S; Long M
    Cell Death Dis; 2022 Apr; 13(4):358. PubMed ID: 35436987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. METTL3/YTHDF2 m6A axis accelerates colorectal carcinogenesis through epigenetically suppressing YPEL5.
    Zhou D; Tang W; Xu Y; Xu Y; Xu B; Fu S; Wang Y; Chen F; Chen Y; Han Y; Wang G
    Mol Oncol; 2021 Aug; 15(8):2172-2184. PubMed ID: 33411363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methyltransferase like 3 promotes colorectal cancer proliferation by stabilizing CCNE1 mRNA in an m6A-dependent manner.
    Zhu W; Si Y; Xu J; Lin Y; Wang JZ; Cao M; Sun S; Ding Q; Zhu L; Wei JF
    J Cell Mol Med; 2020 Mar; 24(6):3521-3533. PubMed ID: 32039568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. METTL3-m6A methylation inhibits the proliferation and viability of type II alveolar epithelial cells in acute lung injury by enhancing the stability and translation efficiency of Pten mRNA.
    Wang Q; Shen J; Luo S; Yuan Z; Wei S; Li Q; Yang Q; Luo Y; Zhuang L
    Respir Res; 2024 Jul; 25(1):276. PubMed ID: 39010105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. METTL3 promotes the growth and metastasis of pancreatic cancer by regulating the m6A modification and stability of E2F5.
    Tang Y; Gao G; Xia WW; Wang JB
    Cell Signal; 2022 Nov; 99():110440. PubMed ID: 35985439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. METTL3 (Methyltransferase Like 3)-Dependent N6-Methyladenosine Modification on
    Li Q; Yu L; Gao A; Ren R; Zhang J; Cao L; Wang X; Liu Y; Qi W; Cai L; Li W; Wang W; Guo X; Su G; Yu X; Zhang J; Xi B; Zhang Y; Zhang M; Zhang C
    Arterioscler Thromb Vasc Biol; 2023 May; 43(5):755-773. PubMed ID: 36951060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The "m6A writer" METTL3 and the "m6A reader" IGF2BP2 regulate cutaneous T-cell lymphomas progression via CDKN2A.
    Wang X; Hu M; Yu L; Wang X; Jiang X; Zhang G; Ding K
    Hematol Oncol; 2022 Oct; 40(4):567-576. PubMed ID: 35446451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
    Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
    Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. METTL3-mediated m
    Jiang L; Liu X; Hu X; Gao L; Zeng H; Wang X; Huang Y; Zhu W; Wang J; Wen J; Meng X; Wu Y
    Mol Ther; 2022 Apr; 30(4):1721-1740. PubMed ID: 34995800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.
    Ai Y; Liu S; Luo H; Wu S; Wei H; Tang Z; Li X; Lv X; Zou C
    J Immunol Res; 2021; 2021():6149558. PubMed ID: 34476262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7).
    Wei K; Gao Y; Wang B; Qu YX
    Bioengineered; 2022 Mar; 13(3):5236-5250. PubMed ID: 35156522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. METTL3 Promotes Osteosarcoma Metastasis via an m6A-dependent Epigenetic Activity of CBX4.
    Huo XS; Lu D; Chen DG; Ye M; Wang XW; Shang FS
    Front Biosci (Landmark Ed); 2024 Mar; 29(3):120. PubMed ID: 38538251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ZBTB7C m6A modification incurred by METTL3 aberration promotes osteosarcoma progression.
    An X; Wu W; Yang L; Dong J; Liu B; Guo J; Chen J; Guo B; Cao W; Jiang Q
    Transl Res; 2023 Sep; 259():62-71. PubMed ID: 37121538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma.
    Liu L; He J; Sun G; Huang N; Bian Z; Xu C; Zhang Y; Cui Z; Xu W; Sun F; Zhuang C; Man Q; Gu S
    Clin Transl Med; 2022 May; 12(5):e778. PubMed ID: 35522946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quercetin ameliorated insulin resistance via regulating METTL3-mediated N6-methyladenosine modification of PRKD2 mRNA in skeletal muscle and C2C12 myocyte cell line.
    Jiao Y; Williams A; Wei N
    Nutr Metab Cardiovasc Dis; 2022 Nov; 32(11):2655-2668. PubMed ID: 36058761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. METTL3 promotes pancreatic cancer proliferation and stemness by increasing stability of ID2 mRNA in a m6A-dependent manner.
    Chen J; Zhang H; Xiu C; Gao C; Wu S; Bai J; Shen Q; Yin T
    Cancer Lett; 2023 Jul; 565():216222. PubMed ID: 37196908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methyltransferase-like 3 enhances cell proliferation and cisplatin resistance in natural killer/T-cell lymphoma through promoting N6-methyladenosine modification and the stability of staphylococcal nuclease and Tudor domain-containing protein 1 mRNA.
    Li N; Wei J; Zhang Q; Zhang Q; Liu B
    Anticancer Drugs; 2023 Jun; 34(5):627-639. PubMed ID: 36730541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.